In vitro susceptibilities of Neisseria gonorrhoeae to fatty acids and monoglycerides

被引：83

作者：

Bergsson, G

Steingrímsson, O

Thormar, H

机构：

[1] Univ Iceland, Inst Biol, IS-108 Reykjavik, Iceland

[2] Natl Univ Hosp, Dept Microbiol, Reykjavik, Iceland

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1999年 / 43卷 / 11期

关键词：

D O I：

10.1128/AAC.43.11.2790

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The susceptibility of Neisseria gonorrhoeae to several medium-chain fatty acids and their l-monoglycerides was tested at a short inactivation time of 1 min. The results indicate that monocaprin, a monoglyceride of capric acid (10 carbon atoms, no double bonds), causes the fastest and most effective killing of all strains of N. gonorrhoeae tested.

引用

收藏

页码：2790 / 2792

页数：3

相关论文

共 16 条

[1]

*AUSTR GON SURV PR, 1998, COMMUN DIS INTELL, V22, P212

[2] In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides [J].

Bergsson, G ;

Arnfinnsson, J ;

Karlsson, SM ;

Steingrímsson, O ;

Thormar, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2290-2294

[3]

BERGSSON G, 1998, ICELANDIC MED J S37, V84, P118

[4] Incidence of gonorrhea in Belgrade, 1988-1994 [J].

Bjekic, M ;

Vlajinac, H ;

Sipetic, S .

JOURNAL OF INFECTION, 1998, 37 (01) :44-47

[5] CHALLENGES FOR THE DEVELOPMENT OF FEMALE-CONTROLLED VAGINAL MICROBICIDES [J].

ELIAS, CJ ;

HEISE, LL .

AIDS, 1994, 8 (01) :1-9

[6] Gonorrhea in the United States, 1981-1996 - Demographic and geographic trends [J].

Fox, KK ;

Whittington, WL ;

Levine, WC ;

Moran, JS ;

Zaidi, AA ;

Nakashima, AK .

SEXUALLY TRANSMITTED DISEASES, 1998, 25 (07) :386-393

[7] Rapid decrease of endemic gonorrhea in Finland [J].

Hiltunen-Back, E ;

Rostila, T ;

Kautiainen, H ;

Paavonen, J ;

Reunala, T .

SEXUALLY TRANSMITTED DISEASES, 1998, 25 (04) :181-186

[8] INACTIVATION OF ENVELOPED VIRUSES IN HUMAN BODILY FLUIDS BY PURIFIED LIPIDS [J].

ISAACS, CE ;

KIM, KS ;

THORMAR, H .

SLOW INFECTIONS OF THE CENTRAL NERVOUS SYSTEM: THE LEGACY OF DR BJORN SIGURDSSON, 1994, 724 :457-464

[9]

ISAACS CE, 1995, J NUTR BIOCHEM, V6, P362, DOI [10.1016/0955-2863(95)80003-U, 10.1016/0955-2863(95)00048-5]

[10]

KABARA JJ, 1978, PHARM EFFECT LIPIDS, P1